Literature DB >> 18509162

Protein phosphatase 3 differentially modulates vascular endothelial growth factor- and fibroblast growth factor 2-stimulated cell proliferation and signaling in ovine fetoplacental artery endothelial cells.

Kai Wang1, Yang Song, Dong-Bao Chen, Jing Zheng.   

Abstract

A critical process for vascular endothelial growth factor (VEGF)- and fibroblast growth factor 2 (FGF2)-regulated cellular function is reversible protein phosphorylation, which is tightly controlled by a balance of protein kinases and phosphatases. We have reported that in ovine fetoplacental artery endothelial (OFPAE) cells, VEGF and FGF2 stimulate cell proliferation in part via activation of mitogen-activated protein kinase kinase 1/2 (MAP2K1/2)/mitogen-activated protein kinase 3/1 (MAPK3/1) and phosphoinositide 3-kinase (PI3K)/v-akt murine thymoma viral oncogene homolog 1 (AKT1) pathways. In the present study, we examined if protein phosphatase 3 (PPP3) mediated VEGF- and FGF2-stimulated OFPAE cell proliferation via modulating activation of MAPK3/1 and AKT1. Small interfering RNA (siRNA) targeting human PPP3 catalytic subunit alpha (PPP3CA) was used to suppress PPP3CA protein expression in OFPAE cells. Compared with the scrambled siRNA, PPP3CA siRNA decreased PPP3CA protein levels by approximately 97% without altering protein levels of protein phosphatase 2 catalytic subunit alpha, total MAPK3/1, total AKT1, or glyceraldehyde-3-phosphate dehydrogenase. Knockdown of PPP3CA protein expression enhanced VEGF-stimulated, but not FGF2-stimulated, cell proliferation. Knockdown of PPP3CA protein expression did not significantly affect VEGF-induced MAPK3/1 and AKT1 phosphorylation but attenuated FGF2-induced MAPK3/1 and AKT1 phosphorylation. Thus, to our knowledge, the present study is the first to demonstrate successful knockdown of PPP3CA protein expression in any cell model using a single pair of double-strained siRNA. Moreover, specific knockdown of PPP3CA protein expression enhances VEGF-stimulated, but not FGF2-stimulated, OFPAE cell proliferation and attenuates FGF2-induced, but not VEGF-induced, MAPK3/1 and AKT1 activation. Thus, PPP3CA differentially modulates the VEGF- and FGF2-stimulated cell proliferation and signaling cascades in OFPAE cells. These data also suggest that signaling molecules other than MAPK3/1 and AKT1 play an important role in VEGF- and FGF2-stimulated cell proliferation after knockdown of PPP3CA in OFPAE cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509162      PMCID: PMC2574765          DOI: 10.1095/biolreprod.108.068957

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  37 in total

1.  Cyclosporin-A inhibits ERK phosphorylation in B cells by modulating the binding of Raf protein to Bcl2.

Authors:  Hélène Gary-Gouy; Alexander Sainz-Perez; Georges Bismuth; Ataollah Ghadiri; Brian A Perrino; Ali Dalloul
Journal:  Biochem Biophys Res Commun       Date:  2006-05-26       Impact factor: 3.575

Review 2.  Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling.

Authors:  Sin-Hyeog Im; Anjana Rao
Journal:  Mol Cells       Date:  2004-08-31       Impact factor: 5.034

Review 3.  Mechanisms underlying differential responses to FGF signaling.

Authors:  Lisa Dailey; Davide Ambrosetti; Alka Mansukhani; Claudio Basilico
Journal:  Cytokine Growth Factor Rev       Date:  2005-03-05       Impact factor: 7.638

4.  Cyclosporine A induces titin expression via MAPK/ERK signalling and improves proliferative and invasive potential of human trophoblast cells.

Authors:  Mei-Rong Du; Wen-Hui Zhou; Feng-Ting Yan; Xiao-Yong Zhu; Yin-Yan He; Jin-Ying Yang; Da-Jin Li
Journal:  Hum Reprod       Date:  2007-07-18       Impact factor: 6.918

Review 5.  Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

Authors:  Anne Marie Byrne; D J Bouchier-Hayes; J H Harmey
Journal:  J Cell Mol Med       Date:  2005 Oct-Dec       Impact factor: 5.310

Review 6.  Protein serine/threonine phosphatases; an expanding family.

Authors:  P T Cohen; N D Brewis; V Hughes; D J Mann
Journal:  FEBS Lett       Date:  1990-08-01       Impact factor: 4.124

Review 7.  Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide.

Authors:  Jing Zheng; Ian M Bird; Dong-Bao Chen; Ronald R Magness
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

Review 8.  Animal models of placental angiogenesis.

Authors:  L P Reynolds; P P Borowicz; K A Vonnahme; M L Johnson; A T Grazul-Bilska; J M Wallace; J S Caton; D A Redmer
Journal:  Placenta       Date:  2005-11       Impact factor: 3.481

9.  Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunit.

Authors:  Brian A Perrino; Andrew J Wilson; Patricia Ellison; Lucie H Clapp
Journal:  Eur J Biochem       Date:  2002-07

10.  Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen-activated protein kinase pathway in ovine fetoplacental artery endothelial cells.

Authors:  Jing Zheng; YunXia Wen; Jason L Austin; Dong-bao Chen
Journal:  Biol Reprod       Date:  2005-10-26       Impact factor: 4.285

View more
  13 in total

1.  GNA11 differentially mediates fibroblast growth factor 2- and vascular endothelial growth factor A-induced cellular responses in human fetoplacental endothelial cells.

Authors:  Qing-Yun Zou; Ying-Jie Zhao; Hua Li; Xiang-Zhen Wang; Ai-Xia Liu; Xin-Qi Zhong; Qin Yan; Yan Li; Chi Zhou; Jing Zheng
Journal:  J Physiol       Date:  2018-05-12       Impact factor: 5.182

2.  Distinct roles of HIF1A in endothelial adaptations to physiological and ambient oxygen.

Authors:  Yi-Zhou Jiang; Yan Li; Kai Wang; Cai-Feng Dai; Shi-An Huang; Dong-Bao Chen; Jing Zheng
Journal:  Mol Cell Endocrinol       Date:  2014-05-02       Impact factor: 4.102

Review 3.  Signaling regulation of fetoplacental angiogenesis.

Authors:  Kai Wang; Jing Zheng
Journal:  J Endocrinol       Date:  2011-11-21       Impact factor: 4.286

4.  An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells.

Authors:  Kai Wang; Yan Li; Yi-Zhou Jiang; Cai-Feng Dai; Manish S Patankar; Jia-Sheng Song; Jing Zheng
Journal:  Cancer Lett       Date:  2013-07-09       Impact factor: 8.679

5.  Rac1-dependent intracellular superoxide formation mediates vascular endothelial growth factor-induced placental angiogenesis in vitro.

Authors:  Su-min Li; Ling-wen Zeng; Lin Feng; Dong-bao Chen
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

6.  Expression and roles of Slit/Robo in human ovarian cancer.

Authors:  Cai Feng Dai; Yi Zhou Jiang; Yan Li; Kai Wang; Pei Shu Liu; Manish S Patankar; Jing Zheng
Journal:  Histochem Cell Biol       Date:  2011-04-05       Impact factor: 4.304

7.  Transcriptional and functional adaptations of human endothelial cells to physiological chronic low oxygen.

Authors:  Yi-Zhou Jiang; Kai Wang; Yan Li; Cai-Feng Dai; Ping Wang; Christina Kendziorski; Dong-Bao Chen; Jing Zheng
Journal:  Biol Reprod       Date:  2013-05-09       Impact factor: 4.285

8.  Suppression of protein phosphatase 2 differentially modulates VEGF- and FGF2-induced signaling in ovine fetoplacental artery endothelial cells.

Authors:  Y Song; K Wang; D-B Chen; R R Magness; J Zheng
Journal:  Placenta       Date:  2009-08-18       Impact factor: 3.481

9.  Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways.

Authors:  K Wang; Y-z Jiang; D-b Chen; J Zheng
Journal:  Placenta       Date:  2009-11-05       Impact factor: 3.481

10.  G Protein α Subunit 14 Mediates Fibroblast Growth Factor 2-Induced Cellular Responses in Human Endothelial Cells.

Authors:  Qing-Yun Zou; Ying-Jie Zhao; Chi Zhou; Ai-Xia Liu; Xin-Qi Zhong; Qin Yan; Yan Li; Fu-Xian Yi; Ian M Bird; Jing Zheng
Journal:  J Cell Physiol       Date:  2018-11-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.